If you have been reading about peptide mapping and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-10-29. Where a claim depends on a specific study, the study is described rather than over-claimed.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Prohibited in sport | Listed by WADA under peptide hormones |
| WADA class | S2 | Peptide hormones, growth factors, related substances, and mimetics |
| Approved therapeutic use | Not established | Clinical research did not lead to broad marketing approval |
| Common detection method | LC-MS/MS | Liquid chromatography-tandem mass spectrometry |
| Sample preparation | Extraction and enrichment | Immunoaffinity or solid-phase extraction may be used |
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography and mass spectrometry. Reversed-phase HPLC separates the peptide from related impurities and can estimate purity by ultraviolet absorbance, while mass spectrometry confirms the molecular mass and detects modifications. Peptide mapping, amino acid analysis, and disulfide mapping may be used when the sequence or disulfide arrangement must be verified. Because AOD9604 contains cysteine residues, oxidation and disulfide isomers are possible quality concerns in synthetic batches.
Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.
AOD9604 is commonly supplied as a white to off-white lyophilized powder. The powder is typically stored at -20 °C or below, protected from light and moisture, because peptides can degrade through oxidation, hydrolysis, or aggregation. If it is reconstituted for laboratory use, an appropriate aqueous buffer or solvent is chosen, and the solution is kept cold and handled to avoid repeated freeze-thaw cycles. These practices support stability but do not imply suitability for human use.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
Gilgo Beach serial killings: Rex Heuermann pleas guilty to killing eight women between 1993 and 2010 on Long Island. Jasveen Sangha is sentenced to 15 years in federal prison for distributing ketamine that resulted in the death of Friends actor Matthew Perry in 2023. April 9 The DNC votes against a resolution to limit AIPAC influence. Melania Trump delivers a rare public statement at the White House denying any connection to Jeffrey Epstein and his associate Ghislaine Maxwell. She calls allegations linking her to Epstein "lies" and urges Congress to hold public hearings for survivors of Epstein's sex trafficking. The FBI launches an antitrust investigation into the NFL. April 10 Iran war: U.S. inflation rises to 3.3% year-on-year in March, a two-year high, driven by higher energy and goods prices linked to disruptions caused by the Iran war. Artemis II successfully returns to Earth, splashing down safely in the Pacific Ocean near San Diego. The four crew members are extracted from the capsule and taken by helicopter to the USS John P Murtha. April 11 Iran and the United States hold ceasefire talks in Islamabad, Pakistan, making it the first highest-level engagement between the two countries since the Iranian Revolution in 1979. The U.S. delegation is led by Vance. The U.S. Central Command has confirmed that the U.S. Navy Arleigh Burke-class destroyers USS Frank Peterson and USS Michael Murphy have crossed the Strait of Hormuz to ensure the strait is clear of sea mines.
=== Medical use === Cryosurgery procedures such as cryoablation use liquid argon to destroy tissue such as cancer cells. It is used in a procedure called "argon-enhanced coagulation", a form of argon plasma beam electrosurgery. The procedure carries a risk of producing gas embolism and has resulted in the death of at least one patient. Blue argon lasers are used in surgery to weld arteries, destroy tumors, and correct eye defects. Argon has also been used experimentally to replace nitrogen in the breathing or decompression mix known as Argox, to speed the elimination of dissolved nitrogen from the blood.
== Genetics == The gene for G-CSF is located on chromosome 17, locus q11.2-q12. Nagata et al. found that the GCSF gene has four introns, and that two different polypeptides are synthesized from the same gene by differential splicing of mRNA. The two polypeptides differ by the presence or absence of three amino acids. Expression studies indicate that both have authentic GCSF activity. It is thought that stability of the G-CSF mRNA is regulated by an RNA element called the G-CSF factor stem-loop destabilising element.
=== James: The Boss's Son === First aired: Online James bullies fellow co-worker Sean. The only problem is that James is the boss's son. Ben Lagman submits James three times in the first round, but James survives the second round, despite taking quite a beating. This was Ben Lagman's first and, so far, only appearance in the series. The episode did not air in regular chronology and is not available on the Bully Beatdown website like most other episodes. It has been leaked on to the internet and it is unknown why the episode was not aired in the regular time slot. This episode has aired, late nights on MTV2.
There are three isoforms of the FGFR1OP2 protein. Transcript variant 1 consists of 253 amino acids and weighs 29.4 kilodaltons. FGFR1OP2's isoelectric point is 5.61. The FGFR1OP2 protein does not have a signal sequences, and therefore is not secreted.
Sources: en.wikipedia.org
== Chemistry == KNX-100 is a synthetic small molecule and peptide fragment of the oxytocin system. Its chemical structure has been disclosed by its developers in a patent. The chemical synthesis of KNX-100 has been described. The small-molecule oxytocin receptor agonists LIT-001 and LIT-002 are derivatives of KNX-100. The more-compact small-molecule oxytocin receptor agonists WJ0679 and CA7 are also analogues of KNX-100.
=== Filming === Scouting began in the beginning of July. The table read for the first episode was announced to occur on July 14, 2015, by Kerry Washington. The title of the season premiere, "Heavy is the Head" was revealed on August 8, 2015, by its director Tom Verica on Twitter. Filming for the season began on July 16, 2015. Several actors working on ShondaLand-produced shows directed an episode for the fifth season. Tony Goldwyn from Scandal directed the second and 17th episodes, making it the fourth and fifth episodes he has directed on the show. Chandra Wilson, who plays Dr. Miranda Bailey on Grey's Anatomy, directed her first Scandal episode, which was the sixth episode "Get Out of Jail, Free". Scott Foley from Scandal also directed his first Scandal episode, the 16th named "The Miseducation of Susan Ross". Foley's director-debut was announced on Twitter by Foley himself and executive producer Tom Verica.
In the United States, religious justifications were first developed in the 19th century and are primarily supported by protestants who believe in dispensationalism. The watchdog group Military Religious Freedom Foundation disclosed they were told that the war was a part of God's plan, and that some military commanders have compared the war to the end times, especially Armageddon, an event in which Jesus returns in what is known as the second coming and is mentioned in the Book of Revelation. One officer complained that he was told by a commander that Donald Trump was anointed by Jesus. Some US politicians are calling for investigations of this. One of the major original complainants of this was himself a Christian. However, the allegations are still unverified. Pete Hegseth, attending a Christian worship service, prayed for there to be "overwhelming violence of action against those who deserve no mercy." This was later met with rebuke by Pope Leo XIV, condemning those who wage war and have "hands full of blood" and stating that God "does not listen to the prayers of those who wage war, but rejects them." On 6 April 2026, Trump asserted that God supports the US–Israeli war on Iran "because God is good, and God wants to see people taken care of." Hegseth, meanwhile, likened the US F-15E rescue operation in Iran to the resurrection of Jesus, stating that the missing airman was rescued from Iranian territory on Easter Sunday.
Unlike her slender sister, Roseanne has always had difficulty controlling her weight, inspiring an episode in which she and Dan go on a diet. Her bad dietary habits are shown to be symptomatic of her emotional health, often overeating fattening foods for comfort when stressed or merely for pleasure and reward. Roseanne is happily married, though Dan's laziness in performing household chores occasionally causes friction. A loving mother, she raises her children to be independent, individualistic, and self-sufficient. She is also close to Jackie, who is neurotic, and insecure, and has many short-term romantic relationships. Her relationship with her parents is more complicated. Her passive-aggressive mother, Bev, dotes on her two daughters, but she is often critical, interfering, and sometimes pits Roseanne and Jackie against each other by exploiting their individual insecurities. Roseanne's father, Al, initially portrayed as jovial and easy-going, is later revealed as a philandering husband and an overly-strict father who used corporal punishment to discipline his daughters over minor offenses, leaving Roseanne unable to trust men, including Dan, for many years. Roseanne later co-owns a moderately successful restaurant, the Lanford Lunch Box, along with Jackie, and her friend Nancy. She and Jackie reluctantly accept their mother Bev as a fourth partner when more money is needed to open the business. Her annoying former Rodbell's luncheonette boss, Leon Carp, becomes a partner after Bev sells him her share as retaliation against Jackie and Roseanne for diminishing her role.
Sources: en.wikipedia.org
Yes, the World Anti-Doping Agency classifies AOD-9604 as a prohibited peptide hormone and related substance. Its use by athletes is banned under the relevant anti-doping code.
Confirmatory detection typically uses liquid chromatography with mass spectrometry. Immunoassays may be used for screening, but mass spectrometry provides structural confirmation.
No widely approved therapeutic indication exists for AOD-9604. It has been investigated in clinical studies, but regulatory approvals for general medical use are not established.
No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.